Early research (Phase 1)Study completedNCT06334393
What this trial is testing
Phase 1 Trial to Assess the Safety and Immunogenicity of an Inactivated, Adjuvanted Whole Zika Virus Vaccine Candidate (VLA1601) in Healthy Adults
Who this might be right for
ZikaZika Virus Infection
Valneva Austria GmbH 150